Delivery Order SPE2D021D0005-SPE2D023F0376
Award Date
5/11/23
Potential Completion Date
6/24/24
Potential Value
$542K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $343,886.48 firm fixed-price delivery order contract to Genentech USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer. This order is placed under an existing contract vehicle and supports the agency's requirement for pharmaceutical products. Genentech holds various indefinite delivery contracts and Federal Supply Schedule agreements with government agencies, allowing them to efficiently procure vital medicines like the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The contract is for the supply of oseltamivir phosphate, an antiviral medication, with a total ceiling value of $259,393.47. The contract is a firm-fixed price delivery order with a completion date of September 20, 2017. Genentech is the prime contractor, and no major subcontractors were identified. The contract is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc. for the pharmaceutical product Activase (alteplase). The $3,256.83 firm-fixed-price contract has an ultimate completion date of August 12, 2024. Genentech, a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics, has provided a range of medical products to federal agencies including the Departments of Defense, Health and Human Services, Justice, and Veterans Affairs. Genentech holds...
This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to Genentech USA, Inc. The contract has a ceiling value of $353,101.26 and is for the delivery of oseltamivir phosphate, an antiviral medication. The contract was awarded under a larger federal supply schedule contract between Genentech and the Department of Veterans Affairs, valued at $4.9 billion, that enables the company to efficiently provide pharmaceuticals and...
The Defense Logistics Agency Troop Support Medical awarded a $172,396.95 firm fixed price delivery order to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company that manufactures pharmaceuticals. This order, which did not utilize a set-aside, was for the antiviral medication oseltamivir phosphate. Genentech, as the prime contractor, will deliver the product from its facility in South San Francisco, California. The agency has previously awarded Genentech various indefinite...
This is a Delivery Order (SPE2DP19F5699) awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Genentech USA, Inc. for the supply of oseltamivir phosphate, an antiviral medication, at a Firm Fixed Price of $95,996.16. The contract has an ultimate completion date of September 3, 2020. Genentech is a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics that holds several contract vehicles with federal agencies, including a $4.9 billion...
This is a delivery order under a Federal Supply Schedule contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of oseltamivir phosphate, an antiviral medication, with a ceiling value of $8,434,278.00 and a period of performance ending on September 20, 2017. The contract does not have a set-aside designation. Genentech holds several key contract vehicles with federal agencies,...
This is a $1,718,296.65 firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate. The contract has no set-aside designation and the work will be performed at Genentech's facility in South San Francisco, CA. Genentech is a biotechnology company that manufactures pharmaceuticals for federal agencies like the Department of Health and Human Services, Department of...
The federal contract award is a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for XGEVA 120 MG/1.7 ML VIAL 1.7ML. The award ceiling value is $60,680.54 and the ultimate completion date is January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XGEVA 120 MG/1.7 ML VIAL 1.7ML. The order has a ceiling value of $7,368.00 and a completion date of February 12, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...